Enzymes play a central role in a spectrum of fundamental physiological processes and their altered expression level has been associated with many diseases and pathological disorders. Enzymes therefore can be exploited as a pristine biological trigger to tune material responses and to achieve controlled release of biomolecules at desired sites. This mini-review highlights enzyme-responsive polymer hydrogels for therapeutic delivery applications developed within the last five years, focusing on protease- and glycosidase-based catalyzed reactions. Strategies employed to produce responsive materials are described. Successful applications for controlled drug delivery are highlighted, and finally, future opportunities and challenges are presented.
MuraSNicolasJCouvreurP. Stimuli-responsive nanocarriers for drug delivery. Nat Mater2013; 12: 991–1003.
2.
ChengRMengFDengCKlokH-AZhongZ. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials2013; 34: 3647–57.
3.
PlaceESEvansNDStevensMM. Complexity in biomaterials for tissue engineering. Nat Mater2009; 8: 457–70.
4.
TibbittMWRodellCBBurdickJAAnsethKS. Progress in material design for biomedical applications. Proc Natl Acad Sci2015; 112: 14444–51.
5.
ShimMSKwonYJ. Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Adv Drug Deliv Rev2012; 64: 1046–59.
6.
SowersMAMcCombsJRWangYPalettaJTMortonSWDreadenECBoskaMDOttavianiMFHammondPTRajcaAJohnsonJA. Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging. Nat Commun2014; 5: 5460–5460.
7.
de la RicaRAiliDStevensMM. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv Drug Deliv Rev2012; 64: 967–78.
8.
HowesPDChandrawatiRStevensMM. Colloidal nanoparticles as advanced biological sensors. Science2014; 346: 1247390–1247390.
9.
SuJChenFCrynsVLMessersmithPB. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. J Am Chem Soc2011; 133: 11850–3.
JumeauxCChapmanRChandrawatiRStevensMM. Synthesis and self-assembly of temperature-responsive copolymers based on N-vinylpyrrolidone and triethylene glycol methacrylate. Polym Chem2015; 6: 4116–22.
13.
ErcoleFDavisTPEvansRA. Photo-responsive systems and biomaterials: photochromic polymers, light-triggered self-assembly, surface modification, fluorescence modulation and beyond. Polym Chem2010; 1: 37–54.
14.
SchöllerKKüpferSBaumannLHoyerPMde CourtenDRossiRMVetushkaAWolfMBrunsNSchererLJ. From membrane to skin: aqueous permeation control through light-responsive amphiphilic polymer co-networks. Adv Funct Mater2014; 24: 5194–201.
15.
ChandrawatiRStädlerBPostmaAConnalLAChongSFZelikinANCarusoF. Cholesterol-mediated anchoring of enzyme-loaded liposomes within disulfide-stabilized polymer carrier capsules. Biomaterials2009; 30: 5988–98.
YanQYuanJCaiZXinYKangYYinY. Voltage-responsive vesicles based on orthogonal assembly of two homopolymers. J Am Chem Soc2010; 132: 9268–70.
18.
WeiJRenLTangCSuZ. Electric-stimulus-responsive multilayer films based on a cobaltocenium-containing polymer. Polym Chem2014; 5: 6480–8.
19.
ZhangSYangSLanJTangYXueYYouJ. Ultrasound-induced switching of sheetlike coordination polymer microparticles to nanofibers capable of gelating solvents. J Am Chem Soc2009; 131: 1689–91.
20.
ChenWDuJ. Ultrasound and pH dually responsive polymer vesicles for anticancer drug delivery. Sci Rep2013; 3: 2162–2162.
GormleyAJChandrawatiRChristoffersonAJLoynachanCJumeauxCArtzy-SchnirmanAAiliDYarovskyIStevensMM. Layer-by-layer self-assembly of polymer films and capsules through coiled-coil peptides. Chem Mater2015; 27: 5820–4.
23.
InestrosaNCAlvarezAPérezCAMorenoRDVicenteMLinkerCCasanuevaOISotoCGarridoJ. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme. Neuron1996; 16: 881–91.
24.
TurkVKosJTurkB. Cysteine cathepsins (proteases)—on the main stage of cancer?Cancer Cell2004; 5: 409–10.
25.
RoyRYangJMosesMA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol2009; 27: 5287–97.
26.
ParkJYunHSLeeKHLeeKTLeeJKLeeS-Y. Discovery and validation of biomarkers that distinguish mucinous and nonmucinous pancreatic cysts. Cancer Res2015; 75: 3227–35.
KelleyEGAlbertJNLSullivanMOEppsTHIII. Stimuli-responsive copolymer solution and surface assemblies for biomedical applications. Chem Soc Rev2013; 42: 7057–71.
36.
HuQKattiPSGuZ. Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale2014; 6: 12273–86.
37.
CoboILiMSumerlinBSPerrierS. Smart hybrid materials by conjugation of responsive polymers to biomacromolecules. Nat Mater2015; 14: 143–59.
38.
TurkB. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov2006; 5: 785–99.
39.
WestJLHubbellJA. Polymeric biomaterials with degradation sites for proteases involved in cell migration. Macromolecules1999; 32: 241–4.
40.
KnopKHoogenboomRFischerDSchubertUS. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed2010; 49: 6288–308.
41.
LinC-C. Recent advances in crosslinking chemistry of biomimetic poly(ethylene glycol) hydrogels. RSC Adv2015; 5: 39844–53.
42.
AndersonSBLinC-CKuntzlerDVAnsethKS. The performance of human mesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels. Biomaterials2011; 32: 3564–74.
43.
SinghSPSchwartzMPTokudaEYLuoYRogersREFujitaMAhnNGAnsethKS. A synthetic modular approach for modeling the role of the 3D microenvironment in tumor progression. Sci Rep2015; 5: 17814–17814.
44.
McCallJDAnsethKS. Thiol–ene photopolymerizations provide a facile method to encapsulate proteins and maintain their bioactivity. Biomacromolecules2012; 13: 2410–7.
45.
PhelpsEAEnemchukwuNOFioreVFSyJCMurthyNSulchekTABarkerTHGarcíaAJ. Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery. Adv Mater2012; 24: 64–70.
46.
SalimathASPhelpsEABoopathyAVCheP-LBrownMGarcíaAJDavisME. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One2012; 7: e50980–e50980.
XuXJhaAKHarringtonDAFarach-CarsonMCJiaX. Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks. Soft Matter2012; 8: 3280–94.
PurcellBPLobbDCharatiMBDorseySMWadeRJZellarsKNDoviakHPettawaySLogdonCBShumanJAFreelsPDGormanJHIIIGormanRCSpinaleFGBurdickJA. Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition. Nat Mater2014; 13: 653–61.
51.
VandenbrouckeRELibertC. Is there new hope for therapeutic matrix metalloproteinase inhibition?Nat Rev Drug Discov2014; 13: 904–27.
52.
GarripelliVKKimJ-KSonSKimWJRepkaMAJoS. Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery. Acta Biomater2011; 7: 1984–92.
53.
GustafsonJAPriceRAFrandsenJHenakCRCappelloJGhandehariH. S Synthesis and characterization of a matrix-metalloproteinase responsive silk–elastinlike protein polymer. Biomacromolecules2013; 14: 618–25.
ProkophSChavakisELeventalKRZierisAFreudenbergUDimmelerSWernerC. Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells. Biomaterials2012; 33: 4792–800.
58.
WataraiASchirmerLThönesSFreudenbergUWernerCSimonJCAndereggU. TGFβ functionalized starPEG-heparin hydrogels modulate human dermal fibroblast growth and differentiation. Acta Biomater2015; 25: 65–75.
59.
ChwalekKTsurkanMVFreudenbergUWernerC. Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models. Sci Rep2014; 4: 4414–4414.
60.
TurkBEHuangLLPiroETCantleyLC. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat Biotech2001; 19: 661–7.
61.
PattersonJHubbellJA. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials2010; 31: 7836–45.
62.
PattersonJHubbellJA. SPARC-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered PEG hydrogels. Biomaterials2011; 32: 1301–10.
63.
WilsonANSalasRGuiseppi-ElieA. Bioactive hydrogels demonstrate mediated release of a chromophore by chymotrypsin. J Control Release2012; 160: 41–7.
64.
HsuC-WOlabisiRMOlmsted-DavisEADavisARWestJL. Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in response to bone resorption. J Biomed Mater Res Part A2011; 98A: 53–62.
SinhaVRKumriaR. Polysaccharides in colon-specific drug delivery. Int J Pharm2001; 224: 19–38.
68.
VandammeTFLenourryACharrueauCChaumeilJC. The use of polysaccharides to target drugs to the colon. Carbohydr Polym2002; 48: 219–31.
69.
ChourasiaMKJainSK. Polysaccharides for colon targeted drug delivery. Drug Deliv2004; 11: 129–48.
70.
HuangRQiWFengLSuRHeZ. Self-assembling peptide-polysaccharide hybrid hydrogel as a potential carrier for drug delivery. Soft Matter2011; 7: 6222–30.
71.
KonoHOtakaFOzakiM. Preparation and characterization of guar gum hydrogels as carrier materials for controlled protein drug delivery. Carbohydr Polym2014; 111: 830–40.
72.
GaoJZhengWZhangJGuanDYangZKongDZhaoQ. Enzyme-controllable delivery of nitric oxide from a molecular hydrogel. Chem Commun2013; 49: 9173–5.
73.
ZhaoQZhangJSongLJiQYaoYCuiYShenJWangPGKongD. Polysaccharide-based biomaterials with on-demand nitric oxide releasing property regulated by enzyme catalysis. Biomaterials2013; 34: 8450–8.
74.
YaoXLiuYGaoJYangLMaoDStefanitschCLiYZhangJOuLKongDZhaoQLiZ. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. Biomaterials2015; 60: 130–40.
75.
FukumuraDKashiwagiSJainRK. The role of nitric oxide in tumour progression. Nat Rev Cancer2006; 6: 521–34.
76.
CarpenterAWSchoenfischMH. Nitric oxide release: part II. Therapeutic applications. Chem Soc Rev2012; 41: 3742–52.
77.
LundbergJOGladwinMTWeitzbergE. Strategies to increase nitric oxide signalling in cardiovascular disease. Nat Rev Drug Discov2015; 14: 623–41.
78.
MocellinSBronteVNittiD. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev2007; 27: 317–52.
79.
EhrbarMRizziSCSchoenmakersRGSan MiguelBHubbellJAWeberFELutolfMP. Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions. Biomacromolecules2007; 8: 3000–7.
80.
MartinoMMBriquezPSRangaALutolfMPHubbellJA. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci2013; 110: 4563–8.
